Troponin levels after cardiac electrophysiology procedures: Review of the literature

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 6, 2009, Pages 800-810

  Alaiti, Mohamad A ^a,b   Maroo, Anjli ^a   Edel, Thomas B ^b  

^a FAIRVIEW HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN;

ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE INJURY; HUMAN; RADIOFREQUENCY ABLATION; REVIEW;

BIOLOGICAL MARKERS; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART; HUMANS; TROPONIN I; TROPONIN T;

EID: 66949171029     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02370.x     Document Type: Review

References (100)

1. Dhoot GK, Gell PG, Perry SV. The localization of the different forms of troponin I in skeletal and cardiac muscle cells. Exp Cell Res 1978 117 : 357 370. (Pubitemid 9076533)
2. Dhoot GK, Perry SV. Distribution of polymorphic forms of troponin components and tropomyosin in skeletal muscle. Nature 1979 278 : 714 718. (Pubitemid 9160272)
3. Takeda S, Yamashita A, Maeda K, Maéda Y. Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature 2003 424 : 35 41. (Pubitemid 36834832)
4. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000 36 : 959 969.
5. Lee TH, Rouan GW, Weisberg MC, Brand DA, Cook EF, Acampora D, Goldman L. Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization. Ann Intern Med 1987 106 : 181 186. (Pubitemid 17009874)
6. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996 335 : 1342 1349. (Pubitemid 26360452)
7. Hamm CW, Ravkilde J, Gerhardt W, Jørgensen P, Peheim E, Ljungdahl L, Goldmann B, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992 327 : 146 150.
8. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000 343 : 1139 1147.
9. Ottani F, Galvani M, Nicolini FA, Ferrini D, Pozzati A, Di Pasquale G, Jaffe AS. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromess. Am Heart J 2000 140 : 917 927.
10. Peacock WF 4th., De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AH., ADHERE Investigators. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008 358 : 2117 2126. (Pubitemid 351679598)
11. Ammann P, Fehr T, Minder EI, Günter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001 27 : 965 969. (Pubitemid 32662476)
12. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, Minder EI, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003 41 : 2004 2009. (Pubitemid 36677123)
13. Arlati S, Brenna S, Prencipe L, Marocchi A, Casella GP, Lanzani M, Gandini C. Myocardial necrosis in ICU patients with acute non-cardiac disease: A prospective study. Intensive Care Med 2000 26 : 31 37. (Pubitemid 30184457)
14. Wright RS, Williams BA, Cramner H, Gallahue F, Willmore T, Lewis L, Ladenson JH, et al. Elevations of cardiac troponin I are associated with increased short-term mortality in noncardiac critically ill emergency department patients. Am J Cardiol 2002 90 : 634 636. (Pubitemid 35264541)
15. Lim W, Qushmaq I, Devereaux PJ, Heels-Ansdell D, Lauzier F, Ismaila AS, Crowther MA, et al. Elevated cardiac troponin measurements in critically ill patients. Arch Intern Med 2006 166 : 2446 2454. (Pubitemid 44913228)
16. Wang, CH, Kuo, LT, Hung, MJ, Cherng, WJ. Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease. Am Heart J 2002 144 : 275 281.
17. Trooyen, M, Indredavik, B, Rossvoll, O, Slordahl, SA. Myocardial injury in acute stroke assessed by troponin I. Tidsskr Nor Laegeforen 2001 121 : 421 425. (Pubitemid 33708054)
18. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, et al. Stretch-induced programmed myocyte cell death. J Clin Invest 1995 96 : 2247 2259.
19. Logeart D, Beyne P, Cusson C, Tokmakova M, Leban M, Guiti C, Bourgoin P, et al. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J 2001 141 : 247 253. (Pubitemid 32128730)
20. Meyer T, Binder L, Hruska N, Luthe H, Buchwald AB. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000 36 : 1632 1636.
21. Cardinale D, Sandri MT, Martinoni A, Tricca A, Civelli M, Lamantia G, Cinieri S, et al. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 2000 36 : 517 522.
22. Brandt RR, Filzmaier K, Hanrath P. Circulating cardiac troponin I in acute pericarditis. Am J Cardiol 2001 87 : 1326 1328. (Pubitemid 32493886)
23. Smith, SC, Ladenson, JH, Mason, JW, Jaffe, AS. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997 95 : 163 168. (Pubitemid 27029958)
24. Knox MA, Hughes HC Jr., Tyers GF, Seidl D, Demers LM. The induction of myocardial damage by open-chest low-energy countershock. Med Instrum 1980 14 : 63 66. (Pubitemid 10156958)
25. Patton JN, Allen JD, Pantridge JF. The effects of shock energy, propranolol, and verapamil on cardiac damage caused by transthoracic countershock. Circulation 1984 69 : 357 368. (Pubitemid 14180341)
26. Doherty PW, McLaughlin PR, Billingham M, Kernoff R, Goris ML, Harrison DC. Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol 1979 43 : 225 232. (Pubitemid 9102527)
27. Allen JD, Pantridge JF, Patton JN. Shock energy and myocardial damage after shocks from DC defibrillators in dogs [proceedings]. J Physiol 1978 285 : 14P 15P.
28. Petelenz T, Gaszewska E, Gruszka A, Iwiński J. Transient ST segment elevation after electrical cardioversion of atrial fibrillation. Przegl Lek 1997 54 : 799 801. Polish.
29. Cantor A. ST elevation after electroversion of atrial fibrillation. Am Heart J 1992 124 : 1666 1667. (Pubitemid 23003626)
30. Van Gelder IC, Crijns HJ, Van der Laarse A, Van Gilst WH, Lie KI. Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter. Am Heart J 1991 121 (1 Pt 1 51 56.
31. Cassin M, Charmet PA, Brieda M, Zanuttini D. ST segment elevation after elective electric cardioversion. Minerva Cardioangiol 1989 37 : 451 456.
32. Siwach SB, Katyal VK. DC cardioversion and coronary artery spasm. J Assoc Physicians India 1989 37 : 545.
33. Ovsyshcher IA, Ilia R, Wanderman KL. Conduction disturbance and ST elevation following cardioversion. Isr J Med Sci 1984 20 : 736 738.
34. Chun PK, Davia JE, Donohue DJ. ST-segment elevation with elective DC cardioversion. Circulation 1981 63 : 220 224. (Pubitemid 11213356)
35. Hartel G, Talvensaari T. Treatment of sinoatrial syndrome with permanent cardiac pacing in 90 patients. Acta Med Scand 1975 198 : 341 347.
36. Albin G, Hayes DL, Holmes DR. Sinus node dysfunction in pediatric and young adult patients: Treatment by implantation of a permanent pacemaker in 39 cases. Mayo Clin Proc 1985 60 : 667 672. (Pubitemid 16191594)
37. Skagen K, Hansen JF. The long term prognosis for patients with sinoatrial block treated with permanent pacemaker. Acta Med Scand 1975 199 : 13 15.
38. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB Jr., Freedman RA, et al. ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 1998 97 : 1325 1335. (Pubitemid 28169189)
39. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, et al. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/NASPE committee to update the 1998 pacemaker guidelines). Circulation 2002 106 : 2145 2161. (Pubitemid 35192824)
40. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, et al. for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disase at high risk for ventricular arrhythmia. N Engl J Med 1996 335 : 1933 1940.
41. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883. (Pubitemid 34984635)
42. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999 341 : 1882 1890.
43. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004 351 : 2481 2488. (Pubitemid 39603155)
44. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, Bitar C, et al. Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. J Am Coll Cardiol 2003 41 : 1707 1712. (Pubitemid 36584239)
45. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237. (Pubitemid 40110811)
46. Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 2002 105 : 1453 1458. (Pubitemid 34263277)
47. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004 350 : 2151 2158. (Pubitemid 38637995)
48. Kuck KH, Cappato R, Siebels J, Ruppel R for the CASH Investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 2000 102 : 748 754. (Pubitemid 30648765)
49. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, et al. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000 101 : 1297 1302. (Pubitemid 30158618)
50. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997 337 : 1576 1583.
51. Morady F. Radio-frequency ablation as treatment for cardiac arrhythmias. N Engl J Med 1999 340 : 534 544. (Pubitemid 29093290)
52. Wittkampf FH, Nakagawa H. RF catheter ablation: Lessons on lesions. Pacing Clin Electrophysiol 2006 29 : 1285 1297. (Pubitemid 44707114)
53. Allan JJ, Feld RD, Russell AA, Ladenson JH, Rogers MA, Kerber RE, Jaffe AS. Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion. J Am Coll Cardiol 1997 30 : 1052 1056. (Pubitemid 27435900)
54. Runsio M, Kallner A, Kallner G, Rosenqvist M, Bergfeldt L. Myocardial injury after electrical therapy for cardiac arrhythmias assessed by troponin-T release. Am J Cardiol 1997 79 : 1241 1245.
55. Boodhoo LE, Mitchell AR, O'Connor J, Sulke N. Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation. Int J Cardiol 2005 103 : 67 72. (Pubitemid 41074607)
56. del Rey Sanchez JM, Hernandez Madrid A, Gonzalez ebollo JM, Pena Perez G, Rodriguez A, Savova D, Cano Calabria L, et al. External and internal electrical cardioversion: Comparative, prospective evaluation of cell damage by means of troponin I. Rev Esp Cardiol 2002 55 : 227 234. (Pubitemid 34326491)
57. Dworschak M, Franz M, Khazen C, Czerny M, Haisjackl M, Hiesmayr M. Mechanical trauma as the major cause of troponin T release after transvenous implantation of cardioverter/defibrillators. Cardiology 2001 95 : 212 214. (Pubitemid 34701481)
58. Sriratanasathavorn C, Leowattana W, Raungratanaamporn O, Krittayaphong R, Bhuripanyo K, Kangkagate C, Charernthai S, et al. Myocardial injury after radiofrequency catheter ablation. J Med Assoc Thai 2000 83 (Suppl 2 S214 S217.
59. The Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979 59 : 607 609.
60. Wu AH, Valdes R Jr., Apple FS, Gornet T, Stone MA, Mayfield-Stokes S, Ingersoll-Stroubos AM, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction and detection of minor myocardial injury. Clin Chem 1994 40 : 900 907.
61. Christenson RH, Apple FS, Morgan DL, Alonsozana GL, Mascotti K, Olson M, McCormack RT, et al. Cardiac troponin I measurement with the ACCESS immunoassay system: Analytical and clinical performance characteristics. Clin Chem 1998 44 : 52 60. (Pubitemid 28042466)
62. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999 45 : 1104 1121. (Pubitemid 29340557)
63. Fox KA, Birkhead J, Wilcox R, Knight C, Barth J British Cardiac Society Working Group. British Cardiac Society Working Group on the definition of myocardial infarction. Heart 2004 90 : 603 609. (Pubitemid 38668524)
64. Georges JL, Spentchian M, Caubel C, Collignon I, Schwob J, Livarek B, Normand JP. Time course of troponin I, myoglobulin, and cardiac enzyme release after electrical cardioversion. Am J Cardiol 1996 78 : 825 826.
65. Cemin R, Rauhe W, Marini M, Pescoller F, Pitscheider W. Serum troponin I level after external electrical direct current synchronized cardioversion in patients with normal or reduced ejection fraction: No evidence of myocytes injury. Clin Cardiol 2005 28 : 467 470. (Pubitemid 41434273)
66. Vikenes K, Omvik P, Farstad M, Nordrehaug JE. Cardiac biochemical markers after cardioversion of atrial fibrillation or atrial flutter. Am Heart J 2000 140 : 690 696.
67. Garre L, Alvarez A, Rubio M, Pellegrini A, Caridi M, Berardi A, Lazzaro C, et al. Use of cardiac troponin T rapid assay in the diagnosis of a myocardial injury secondary to electrical cardioversion. Clin Cardiol 1997 20 : 619 621. (Pubitemid 127745541)
68. Neumayr G, Hagn C, Ganzer H, Friedrich G, Pechlaner C, Joannidis M, Schratzberger P, et al. levels of troponin T after electrical cardioversion of atrial fibrillation and flutter. Am J Cardiol 1997 80 : 1367 1369. (Pubitemid 27513346)
69. Neumayr G, Schratzberger P, Friedrich G, Gänzer H, Wiedermann CJ. Effect of electrical cardioversion on myocardial cells in patients in intensive care. BMJ 1998 316 : 1207 1210.
70. Grubb NR, Cuthbert D, Cawood P, Flapan AD, Fox KA. Effect of DC shock on serum levels of total creatine kinase, MB-creatine kinase mass and troponin T. Resuscitation 1998 36 : 193 199. (Pubitemid 28221214)
71. Rao AC, Naeem N, John C, Collinson PO, Canepa-Anson R, Joseph SP. Direct current cardioversion does not cause cardiac damage: Evidence from cardiac troponin T estimation. Heart 1998 80 : 229 230. (Pubitemid 28440338)
72. Greaves K, Crake T. Cardiac troponin T does not increase after electrical cardioversion for atrial fibrillation or atrial flutter. Heart 1998 80 : 226 228. (Pubitemid 28440337)
73. Bonnefoy E, Chevalier P, Kirkorian, Guidolet J, Marchand A, Touboul P. Cardiac troponin I does not increase after cardioversion. Chest 1997 111 : 15 18. (Pubitemid 27043600)
74. Santos ES, Pereira MP, Minuzzo L, Moreira DA, Ramos R, Avezum A, Timerman A, et al. Electrical cardioversion and myocardial injury: Evaluation by new cardiac injury markers. Arq Bras Cardiol 2006 86 : 191 197.
75. Lund M, French JK, Johnson RN, Williams BF, White HD. Serum troponins T and I after elective cardioversion. Eur Heart J 2000 21 : 245 253. (Pubitemid 30137810)
76. Skulec R, Belohlavek J, Kovarnik T, Kolar J, Gandalovicova J, Dytrych V, Linhart A, et al. Serum cardiac markers response to biphasic and monophasic electrical cardioversion for supraventricular tachyarrhythmia-a randomised study. Resuscitation 2006 70 : 423 431. (Pubitemid 44389721)
77. Kosior DA, Opolski G, Tadeusiak W, Chwyczko T, Wozakowska-Kaplon B, Stawicki S, Filipak KJ, et al. Serum troponin I and myoglobin after monophasic versus biphasic transthoracic shocks for cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 2005 28 (Suppl 1 S128 S132.
78. Goktekin O, Melek M, Gorenek B, Birdane A, Kudaiberdieva G, Cavusoglu Y, Timuralp B. Cardiac troponin T and cardiac enzymes after external transthoracic cardioversion of ventricular arrhythmias in patients with coronary artery disease. Chest 2002 122 : 2050 2054. (Pubitemid 36051143)
79. Boriani G, Biffi M, Cervi V, Bronzetti G, Magagnoli G, Zannoli R, Branzi A. Evaluation of myocardial injury following repeated internal atrial shocks by monitoring serum cardiac troponin I levels. Chest 2000 118 : 342 347. (Pubitemid 30637797)
80. Gorenek B, Kudaiberdieva G, Goktekin O, Cavusoglu Y, Birdane A, Ata N, Unalir A, et al. Detection of myocardial injury after internal cardioversion for atrial fibrillation. Can J Cardiol 2004 20 : 165 168. (Pubitemid 38401273)
81. Yalcin R, Kaya MG, Ozdemir M, Cemri M, Timurkaynak T, Boyaci B, Cengel A. Prospective randomized trial of transthoracic versus low-energy transvenous internal cardioversion in persistent atrial fibrillation. Acta Cardiol 2004 59 : 521 526. (Pubitemid 39331224)
82. Nikolaou NI, Spanodimos SG, Tsaglis EP, Antonatos DG, Patsilinakos SP, Fournarakis GM, Tsigas DL. Biochemical evidence of cardiac damage following transvenous implantation of a permanent antibradycardia pacemaker lead. Pacing Clin Electrophysiol 2005 28 : 1174 1181. (Pubitemid 43943004)
83. Hurst TM, Hinrichs M, Breidenbach C, Katz N, Waldecker B. Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol 1999 34 : 402 408.
84. Joglar JA, Kessler J, Welch PJ, Keffer JH, Jessen ME, Hamdan MH, Page RL. Effects of repeated electrical defibrillations on cardiac troponin I levels. Am J Cardiol 1999 83 : 270 272, A6. (Pubitemid 29047312)
85. Schluter T, Baum H, Plewan A, Neumeier D. Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. Clin Chem 2001 47 : 459 463. (Pubitemid 32223520)
86. Hasdemir C, Shah N, Rao AP, Acosta H, Matsudaira K, Neas BR, Reynolds DW, et al. Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. J Cardiovasc Electrophysiol 2002 13 : 144 150. (Pubitemid 34211918)
87. del Rey JM, Madrid AH, Novo L, Sanchez A, Martin J, Rubi J, Pallares E, et al. Evaluation of biochemical markers of myocardial lesion after radiofrequency ablation. Value of troponin I. Rev Esp Cardiol 1997 50 : 552 560. (Pubitemid 127517460)
88. Manolis AS, Vassilikos V, Maounis T, Melita-Manolis H, Psarros L, Haliasos A, Cokkinos DV. Detection of myocardial injury during radiofrequency catheter ablation by measuring serum cardiac troponin I levels: Procedural correlates. J Am Coll Cardiol 1999 34 : 1099 1105. (Pubitemid 29500545)
89. Hirose H, Kato K, Suzuki O, Yoshida T, Oguri M, Yajima K, Hibino T, et al. Diagnostic accuracy of cardiac markers for myocardial damage after radiofrequency catheter ablation. J Interv Card Electrophysiol 2006 16 : 169 174. (Pubitemid 46020552)
90. Katritsis DG, Hossein-Nia M, Anastasakis A, Poloniecki J, Holt DW, Camm AJ, Ward DE, et al. Myocardial injury induced by radiofrequency and low energy ablation: A quantitative study of CK isoforms, CK-MB, and troponin-T concentrations. Pacing Clin Electrophysiol 1998 21 : 1410 1416. (Pubitemid 28323492)
91. Carlsson J, Erdogan A, Guettler N, Schulte B, Lay D, Neuzner J, Hamm CW, et al. Myocardial injury during radiofrequency catheter ablation: Comparison of focal and linear lesions. Pacing Clin Electrophysiol 2001 24 : 962 968. (Pubitemid 32681209)
92. Brueckmann M, Wolpert C, Bertsch T, Sueselbeck T, Liebetrau C, Kaden JJ, Huhle G, et al. Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2004 15 : 686 691. (Pubitemid 38757175)
93. Gupta A, Halankar S, Vora AM, Lokhandwala YY. Does radiofrequency ablation increase creatine kinase and troponin-T? Indian Heart J 1999 51 : 418 421.
94. Haegeli LM, Kotschet E, Byrne J, Adam DC, Lockwood EE, Leather RA, Sterns LD, et al. Cardiac injury after percutaneous catheter ablation for atrial fibrillation. Europace 2008 10 : 273 275. (Pubitemid 351773724)
95. Emkanjoo Z, Mottadayen M, Givtaj N, Alasti M, Arya A, Haghjoo M, Fazelifar AF, et al. Evaluation of post-radiofrequency myocardial injury by measuring cardiac troponin I levels. Int J Cardiol 2006.
96. Sribhen K, Bhuripanyo K, Raungratanaamporn O, Kiartivich S, Leowattana W, Chaithiraphan S. Improved detection of radiofrequency current-induced minor myocardial injury by cardiac troponin T measurement. J Med Assoc Thai 1999 82 : 256 262.
97. Shyu KG, Lin JL, Chen JJ, Chang H. Use of cardiac troponin T, creatine kinase and its isoform to monitor myocardial injury during radiofrequency ablation for supraventricular tachycardia. Cardiology. 1996 87 : 392 295.
98. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000 36 : 959 969.
99. Thygesen K, Alpert JS, White HD Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007 50 : 2173 2195. (Pubitemid 350123680)
100. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, Mair J, et al., Committee on Standardization of Markers of Cardiac Damage of the IFCC. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004 50 : 327 332. Epub 2003 Dec 4. (Pubitemid 38156373)